Diab, Hassan
Langén, Ville
Yeo, Li-Fang
Salomaa, Veikko
Havulinna, Aki
Lahti, Leo
Pärnänen, Katariina
Knight, Rob
Jalkanen, Sirpa
Salmi, Marko
Niiranen, Teemu
Palmu, Joonatan
Article History
Received: 21 May 2025
Accepted: 14 August 2025
First Online: 26 August 2025
Declarations
:
: The FINRISK 2002 study complies with the Declaration of Helsinki. The Coordinating Ethics Committee of the Helsinki and Uusimaa University Hospital District approved the FINRISK 2002 study. All participants provided written informed consent.
: Not applicable.
: RK is a scientific advisory board member, and consultant for BiomeSense, Inc., has equity and receives income. He is a scientific advisory board member and has equity in GenCirq. He has equity in and acts as a consultant for Cybele. He is a co-founder of Biota, Inc., and has equity. He is a cofounder of Micronoma and has equity and is a scientific advisory board member. He is a board member of Microbiota Vault, Inc. He is a board member of N=1 IBS advisory board and receives income. He is a Senior Visiting Fellow of HKUST Jockey Club Institute for Advanced Study. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. TN has received consulting or lecturing fees from AstraZeneca and Orion Corporation.